1H-1-ethyl Candesartan Cilexetil
CAS No. 914613-35-7
1H-1-ethyl Candesartan Cilexetil ( Candesartan Cilexetil Impurity E )
产品货号. M27433 CAS No. 914613-35-7
1H-1-ethyl Candesartan Cilexetil is a process-related impurity in the bulk synthesis of candesartan cilexetil, which is a potent, long-acting and selective angiotensin II type 1 receptor (AT1) antagonist.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1839 | 有现货 |
|
10MG | ¥2770 | 有现货 |
|
25MG | ¥4674 | 有现货 |
|
50MG | ¥6699 | 有现货 |
|
100MG | ¥9153 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称1H-1-ethyl Candesartan Cilexetil
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述1H-1-ethyl Candesartan Cilexetil is a process-related impurity in the bulk synthesis of candesartan cilexetil, which is a potent, long-acting and selective angiotensin II type 1 receptor (AT1) antagonist.
-
产品描述1H-1-ethyl Candesartan Cilexetil is a process-related impurity in the bulk synthesis of candesartan cilexetil, which is a potent, long-acting and selective angiotensin II type 1 receptor (AT1) antagonist.
-
同义词Candesartan Cilexetil Impurity E
-
通路Others
-
靶点Other Targets
-
受体Apoptosis
-
研究领域——
-
适应症——
化学信息
-
CAS Number914613-35-7
-
分子量638.7
-
分子式C35H38N6O6
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnnn1CC
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Zhao RL, et al. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice. J Ethnopharmacol. 2018 Jan 10;210:287-295.
产品手册
关联产品
-
HQNO
HQNO is a natural product isolated from P. aeruginosa,and is a potent inhibitor of electron transport chain(Kd of 64 nM for complex III).
-
Jatrorrhizine
Jatrorrhizine is a protoberberine alkaloid isolated from Enantia chlorantha (Annonaceae) and other species.
-
NGR peptide Trifluor...
NGR peptide Trifluoroacetate containing the asparagine-glycine-arginine (NGR) motif is recognized by CD13/aminopeptidase N (APN) receptor isoforms that are selectively overexpressed in tumor neovasculature.